摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Calcitriol (Rocaltrol) | 32222-06-3

中文名称
——
中文别名
——
英文名称
Calcitriol (Rocaltrol)
英文别名
(1R,3S,5Z)-5-[2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
Calcitriol (Rocaltrol)化学式
CAS
32222-06-3
化学式
C27H44O3
mdl
——
分子量
416.6
InChiKey
GMRQFYUYWCNGIN-HVIYGYGUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    119-1210C
  • 比旋光度:
    D25 +48° (methanol)
  • 沸点:
    474.91°C (rough estimate)
  • 密度:
    1.0362 (rough estimate)
  • 闪点:
    14 °C
  • 最大波长(λmax):
    265nm(lit.)
  • 颜色/状态:
    Colorless, crystalline solid
  • 溶解度:
    In water, 7.9X10-4 mg/L at 25 °C (est)
  • 蒸汽压力:
    1.2X10-12 mm Hg at 25 °C (est)
  • 亨利常数:
    Henry's Law constant = 3.1X10-7 atm cu-m/mol at 25 °C (est)
  • 稳定性/保质期:
    Calcitriol will degrade during prolonged exposure to light.
  • 旋光度:
    Specific optical rotation = +48 deg at 22 °C/D (methanol)

计算性质

  • 辛醇/水分配系数(LogP):
    5.1
  • 重原子数:
    30
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.78
  • 拓扑面积:
    60.7
  • 氢给体数:
    3
  • 氢受体数:
    3

ADMET

代谢
钙三醇是维生素D3(胆钙化醇)的活性形式。人体内自然或内源性的维生素D供应主要依赖于紫外线,用于将皮肤中的7-脱氢胆固醇转化为维生素D3。维生素D3在肝脏和肾脏中必须经过代谢激活,才能在其靶组织中完全发挥作用。最初的转化由肝脏中的维生素D3-25-羟化酶酶催化,这个反应的产物是25-(OH)D3(钙化二醇)。后者在肾脏组织的线粒体中发生羟基化,这个反应由肾脏的25-羟维生素D3-1α-羟化酶激活,以产生1,25-(OH)2D3(钙三醇),即维生素D3的活性形式。
Calcitriol is the active form of vitamin D3 (cholecalciferol). The natural or endogenous supply of vitamin D in man mainly depends on ultraviolet light for conversion of 7-dehydrocholesterol to vitamin D3 in the skin. Vitamin D3 must be metabolically activated in the liver and the kidney before it is fully active on its target tissues. The initial transformation is catalyzed by a vitamin D3-25-hydroxylase enzyme present in the liver, and the product of this reaction is 25-(OH)D3 (calcifediol). The latter undergoes hydroxylation in the mitochondria of kidney tissue, and this reaction is activated by the renal 25-hydroxyvitamin D3-1-a-hydroxylase to produce 1,25-(OH)2D3 (calcitriol), the active form of vitamin D3.
来源:Hazardous Substances Data Bank (HSDB)
代谢
1,25-二羟基胆固醇钙化醇(钙三醇)和1,25-二羟基麦角钙化醇似乎代谢为它们各自的三羟基代谢物(即1,24,25-三羟基胆固醇钙化醇,1,24,25-三羟基麦角钙化醇)以及其他化合物。尿液中最主要的代谢物是钙三酸,它更具水溶性。尽管尚未识别出胆固醇钙化醇和麦角钙化醇的所有代谢物,但肝脏微粒体酶可能参与降解麦角钙化醇和胆固醇钙化醇的代谢物。
1,25-Dihydroxycholecalciferol (calcitriol) and 1,25-dihydroxyergocalciferol appear to be metabolized to their respective trihydroxy metabolites (i.e., 1,24,25-trihydroxycholecalciferol, 1,24,25-trihydroxyergocalciferol) and to other compounds. The principal metabolite excreted in urine is calcitroic acid, which is more water soluble. Although all the metabolites of cholecalciferol and ergocalciferol have not been identified, hepatic microsomal enzymes may be involved in degrading metabolites of ergocalciferol and cholecalciferol.
来源:Hazardous Substances Data Bank (HSDB)
代谢
钙三醇(1,25-二羟基维生素D)通过一种由钙三醇诱导并由刺激25-OHD-1-α-羟化酶的因素所抑制的肾脏羟化酶,被羟化成1,24,25-(OH)3-D。这种酶还将25-OHD羟化成24,25-(OH)2D。这两种24-羟基化合物的活性均低于钙三醇,推测它们是注定要被排出的代谢物。钙三醇的侧链氧化也会发生。
Calcitriol /(1,25-dihydroxy-vitamin D)/ is hydroxylated to 1,24,25-(OH)3-D by a renal hydroxylase that is induced by calcitriol and suppressed by those factors that stimulate the 25-OHD-1-alpha-hydroxylase. This enzyme also hydroxylates 25-OHD to form 24,25-(OH)2D. Both 24-hydroxylated compounds are less active than calcitriol and presumably represent metabolites destined for excretion. Side chain oxidation of calcitriol also occurs.
来源:Hazardous Substances Data Bank (HSDB)
代谢
为了评估每日和禁食状态下尿钙排泄与血清1,25-二羟基维生素D(II)浓度之间的关系,对6名健康男性进行了研究,包括对照期和慢性口服钙三醇(I)给药期(每6小时0.6、1.2或1.8纳米摩尔,持续6-12天),同时他们食用正常和低钙饮食(19.2或4.2毫摩尔/天钙)。每日尿钙排泄与血清II浓度直接相关,但在食用正常钙饮食时增加更多,而在食用低钙饮食时增加较少。在I给药和摄入低钙饮食期间,每日尿钙排泄平均为7.32毫摩尔/天,超过了饮食中钙的摄入量。无论哪种饮食,禁食尿钙/肌酐都超过了0.34毫摩尔/毫摩尔(正常的上限)。当血清II浓度升高时,即使是在低钙饮食下,高禁食尿钙/肌酐或高每日尿钙排泄也不能作为肾钙漏诊断的充分依据。
To evaluate the relation between daily and fasting urinary calcium excretion and serum 1,25-dihydroxyvitamin D (II) concentrations, 6 healthy men were studied during control and during chronic oral calcitrol (I) administration (0.6, 1.2, or 1.8 nmols every 6 hours for 6-12 days) while they ate normal and low calcium diets (19.2 or 4.2 mmols Ca/day). Daily urinary calcium excretion was directly related to serum II concentrations, but increased more while subjects ate the normal calcium diet than when eating the low calcium diet. During I and ingestion of the low calcium diet, daily urinary calcium excretion averaged 7.32 mmole/day, exceeding the dietary calcium intake. Fasting urinary calcium/creatinine exceeded 0.34 mmol/mmol (the upper limit of normal) on either diet. When serum II concentrations are elevated, a high fasting urinary calcium/creatinine or high daily urinary calcium excretion, even on a low calcium diet, is insufficient criteria for the documentation of a renal calcium leak.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 相互作用
皮质类固醇抵消维生素D类似物的作用。/维生素D类似物/
Corticosteroids counteract the effects of vitamin D analogs. /Vitamin D analogs/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 相互作用
噻嗪类利尿剂和药理剂量的维生素D类似物在患有低甲状旁腺功能的病人中同时使用可能会导致高钙血症,这种情况可能是暂时的、自限性的,或者可能需要停止使用维生素D类似物。低甲状旁腺患者中由噻嗪类引起的高钙血症可能是由于骨骼中钙的释放增加所致。/维生素D类似物/
Concurrent administration of thiazide diuretics and pharmacologic doses of vitamin D analogs in patients with hypoparathyroidism may result in hypercalcemia which may be transient and self-limited or may require discontinuance of vitamin D analogs. Thiazide-induced hypercalcemia in hypoparathyroid patients is probably caused by increased release of calcium from bone. /Vitamin D analogs/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 相互作用
过度使用矿物油可能会干扰肠道对维生素D类似物的吸收。/维生素D类似物/
Excessive use of mineral oil may interfere with intestinal absorption of vitamin D analogs. /Vitamin D analogs/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 相互作用
奥利司他可能会导致脂肪溶性维生素,如维生素D类似物的胃肠道吸收减少。在任何奥利司他剂量和维生素D类似物给药之间(之前或之后)至少应间隔2小时……../维生素D类似物/
Orlistat may result in decreased GI absorption of fat-soluble vitamins such as vitamin D analogs. At least 2 hours should elapse between (before or after) any orlistat dose and vitamin D analog administration ... . /Vitamin D analogs/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 解毒与急救
Calcijex(钙三醇注射液)急性意外过量的治疗应包括一般支持性措施。应获取连续的血电解质测定(特别是钙),尿钙排泄率和由于高钙血症导致的心电图异常的评估。在接受地高辛的患者中,这种监测至关重要。在意外过量的情况下,也应停止补充钙和低钙饮食。由于钙三醇的药理作用相对较短,进一步的措施可能是不必要的。然而,如果出现持续和明显升高的血钙水平,可以根据患者的潜在状况考虑多种治疗选择。这些包括使用磷酸盐和皮质类固醇等药物,以及采取措施诱导适当的强迫利尿。也有报道称使用无钙透析液进行腹膜透析。
The treatment of acute accidental overdosage of Calcijex (calcitriol injection) should consist of general supportive measures. Serial serum electrolyte determinations (especially calcium), rate of urinary calcium excretion and assessment of electrocardiographic abnormalities due to hypercalcemia should be obtained. Such monitoring is critical in patients receiving digitalis. Discontinuation of supplemental calcium and low calcium diet are also indicated in accidental overdosage. Due to the relatively short duration of the pharmacological action of calcitriol, further measures are probably unnecessary. Should, however, persistent and markedly elevated serum calcium levels occur, there are a variety of therapeutic alternatives which may be considered, depending on the patients' underlying condition. These include the use of drugs such as phosphates and corticosteroids as well as measures to induce an appropriate forced diuresis. The use of peritoneal dialysis against a calcium-free dialysate has also been reported.
来源:Hazardous Substances Data Bank (HSDB)
吸收、分配和排泄
许多维生素D类似物在口服给药后,如果脂肪吸收正常,很容易从胃肠道吸收。胆汁的存在是吸收麦角钙化醇所必需的,患有肝脏、胆道或胃肠道疾病(例如,克罗恩病、惠普尔病、乳糜泻)的患者的胃肠道吸收程度可能会降低。因为维生素D是脂溶性的,它被并入乳糜微粒并通过淋巴系统吸收;大约80%摄入的维生素D似乎是通过这种机制被全身吸收的,主要在小肠。尽管一些证据表明,老年成人的肠道对维生素D的吸收可能会降低,但其他证据并未显示在治疗剂量下,维生素D的胃肠道吸收有临床重要的年龄相关改变。目前尚不清楚衰老是否改变生理剂量的维生素D的胃肠道吸收。/维生素D类似物/
Many vitamin D analogs are readily absorbed from the GI tract following oral administration if fat absorption is normal. The presence of bile is required for absorption of ergocalciferol and the extent of GI absorption may be decreased in patients with hepatic, biliary, or GI disease (e.g., Crohn's disease, Whipple's disease, sprue). Because vitamin D is fat soluble, it is incorporated into chylomicrons and absorbed via the lymphatic system; approximately 80% of ingested vitamin D appears to be absorbed systemically through this mechanism, principally in the small intestine. Although some evidence suggested that intestinal absorption of vitamin D may be decreased in geriatric adults, other evidence did not show clinically important age-related alterations in GI absorption of the vitamin in therapeutic doses. It currently is not known whether aging alters the GI absorption of physiologic amounts of vitamin D. /Vitamin D analogs/
来源:Hazardous Substances Data Bank (HSDB)
吸收、分配和排泄
口服卡利三醇后,在大约2小时后,消化道中的钙吸收才会增加。最大升高血钙效果在大约10小时出现,卡利三醇的作用持续时间为3-5天。
After oral administration of calcitriol, there is about a 2-hour lag-time before calcium absorption in the GI tract increases. Maximal hypercalcemic effect occurs in about 10 hours, and the duration of action of calcitriol is 3-5 days.
来源:Hazardous Substances Data Bank (HSDB)
吸收、分配和排泄
达到峰值血清浓度的时间:口服:大约3到6小时。
Time to peak serum concentration: Oral: Approximately 3 to 6 hours.
来源:Hazardous Substances Data Bank (HSDB)
吸收、分配和排泄
维生素D的主要排泄途径是胆汁;只有很小一部分摄入剂量会出现在尿液中。
The primary route of excretion of vitamin D is the bile; only a small percentage of an administered dose is found in urine. /Vitamin D/
来源:Hazardous Substances Data Bank (HSDB)

安全信息

  • 危险等级:
    6.1(a)
  • 危险品标志:
    T+
  • 安全说明:
    S36/37/39,S45
  • 危险类别码:
    R26/27/28,R63
  • WGK Germany:
    3
  • 海关编码:
    2942000000
  • 危险品运输编号:
    UN 2811 6.1/PG 1
  • 危险类别:
    6.1(a)
  • RTECS号:
    FZ4645000
  • 包装等级:
    I
  • 危险标志:
    GHS06
  • 危险性描述:
    H300
  • 危险性防范说明:
    P260,P262,P280,P301+P310+P330,P302+P352+P310,P304+P340+P310,P403+P233

SDS

SDS:74744d49769e49350561d6dc29edfcd3
查看

制备方法与用途

二羟胆钙化醇

二羟胆钙化醇,即维生素1α,25-D3的重要活性代谢物,通常在肾脏内形成。近年来研究发现,除了肾脏外,胎盘、单核细胞、巨噬细胞、肿瘤细胞上清液、结节病患者淋巴结和角朊细胞中也存在1α羟化酶,能够产生钙三醇。

二羟胆钙化醇的前体是25-羟基胆钙化醇(阿法骨化醇)。该代谢物能促进小肠吸收钙并调节骨质中的无机盐转运等作用。

适应症

适用于慢性肾功能衰竭病人的肾性营养不良、甲状旁腺机能低下,维生素D依赖性佝偻病及抗维生素D佝偻病。

生理作用 钙三醇(骨化三醇)

钙三醇又名骨化三醇,是维生素D的活性形式,也是一种激素,在调节血钙与血磷浓度方面起重要作用。通过增加肠道的钙离子吸收来提高血液中的钙水平,并可增加骨中钙的释放以提高血钙水平。此研究由Michael F. Holick于1971年首次报道。

作用机制

钙三醇主要通过与其维生素D受体(VDR)结合发挥作用,如小肠上皮细胞胞质中的受体与钙三醇结合形成的配体-受体复合物转移到细胞核中作为促进钙结合蛋白的编码基因表达的转录因子。钙结合蛋白增加使细胞主动运输更多钙离子,从而提高钙吸收水平。同时,为维持电中性需要运输阴离子,主要是无机磷酸根离子,因此钙三醇也促进了磷的吸收。

临床应用

临床上可用于治疗低血钙症、甲状旁腺功能减退症(成人)、骨软化症、佝偻病(婴幼儿)、慢性肾脏病、肾性骨病及预防糖皮质激素引起的骨质疏松症。

生物活性

Calcitriol (RO215535, Topitriol, 1,25-Dihydroxyvitamin D3) 是维生素D的激素活性形式,是一种非选择性维生素D受体激活剂,对维生素D受体(VDR)的结合亲和力(IC50=0.4 nM)是选择性VDRA paricalcitol的10倍以上。建议现配现用。

靶点
  • Target:vitamin D receptor (Cell-free assay)
体外研究

Calcitriol 是PHA诱导淋巴细胞增殖的有效抑制剂,在培养72小时后可抑制70%氚标记的胸腺嘧啶核苷掺入。它以浓度依赖性方式抑制PHA刺激的外周血单核细胞中白细胞介素-2(IL-2)的生产。Calcitriol 在5秒内增加细胞内钙离子浓度,通过从内质网和肌醇1,4,5-三磷酸肌醇及甘油二酯的形成动员钙。Calcitriol 能抑制人前列腺腺癌细胞增殖并促进其分化,选择性降低IV型胶原酶(MMP-2和MMP-9)的分泌水平。在鳞状细胞癌和前列腺癌中,Calcitriol 具有抗增殖活性,并增强基于铂的药物的抗肿瘤活性,在小鼠鳞状细胞癌及PC-3细胞中比paclitaxel更强。Calcitriol 作为多种恶性细胞类型的有效抗增殖剂,通过增加G0/G1期阻滞、诱导细胞凋亡和分化,调节生长因子受体表达发挥作用。它还能促进许多细胞毒性剂的抗肿瘤作用,并抑制肿瘤细胞的侵袭性和形成新血管。

用途

维生素类药,用于慢性肾功能衰竭患者的肾性骨营养不良。

类别

有毒物品

毒性分级

高毒

急性毒性
  • 口服-大鼠 LD50:0.62毫克/公斤
  • 口服-小鼠 LD50:1.35毫克/公斤
可燃性危险特性

可燃,火场排出辛辣刺激烟雾

储运特性

库房通风、低温干燥;与食品分开储运

灭火剂

水、砂土